Category Archives: Cuban Medicine

Cuba develops new hip prosthesis

Cuba develops new hip prosthesis
Cuba presented a homegrown hip prosthesis to meet the domestic demand, especially among the elderly, a demographic segment that represents a little more than 20 percent of the population.

Author: Radio Habana Cuba | internet@granma.cu

february 17, 2023 08:02:50

Photo: Estudios Revolución

Havana, Feb 16 (RHC) Cuba presented a homegrown hip prosthesis to meet the domestic demand, especially among the elderly, a demographic segment that represents a little more than 20 percent of the population.
Cuban President Miguel Diaz-Canel described as a success of Cuban science the prototype that was unveiled during the regular meeting of experts and scientists on medical issues.
According to information from the Presidency of the Republic, the project is the result of collaboration among several institutions, including the Public Health Ministry and the Union of Military Industry of the Revolutionary Armed Forces (FAR).
Companies, universities, and private stockholders also participated, among them the self-employed worker Osbel Fleitas, who devised a welding machine, an innovative and essential element for the production of the prostheses.
In November 2022, the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) granted Exceptional Use Authorization to this product, which is currently in Phase III of Clinical Trials, which has allowed its use in 38 patients.
The specialist in orthopedics and traumatology Roberto Balmaseda said that the people treated at the Fructuoso Rodriguez Hospital have not presented any technical complications during the surgical procedure, nor are there any adverse reactions or infections after the implants.
The expert considered that in the medium term, Cuba will be in a position to obtain technological sovereignty regarding these prostheses, since the industry is currently capable of producing 150 of these devices every month.
Diaz-Canel pointed out that beyond what has been achieved, this work opens the way for the development of other kinds of prostheses that are also needed in the country. (Source: PL)

SHARE facebook twitter

Cuban vaccine against lung cancer makes its way in the United States

 

Cuban vaccine against lung cancer makes its way in the United States

Originally published: Granma English by Granma English (more by Granma English) | (Posted Aug 06, 2022)

Health, Movements, StrategyAmericas, Cuba, United StatesNewswireCenter for Molecular Immunology (CIM), Cimavax-EGF, Innovative Immunotherapy Alliance, Lung Cancer, Roswell Park Cancer Research Center
Cimavax-EGF, a Cuban therapeutic vaccine against lung cancer, conquers the scientific community and the population of the United States based on the achievements compiled in studies carried out. The vaccine was obtained after more than two decades of research and have shown satisfactory results in patients in advanced stages of lung cancer.

The Cuban Center for Molecular Immunology (CIM) and the Roswell Park Cancer Research Center in Buffalo, in the United States of America, joined forces a few years ago to facilitate access to equipment and reagents in order to promote the development of the drug, reported Russia Today.

The creation of the only joint venture between Cuba and the United States, the Innovative Immunotherapy Alliance, a biotechnological company to insert the drug in the U.S. society, facilitated Cuba’s access to equipment and reagents which are very difficult to obtain due to the limitations of the coercive measure of the economic, financial and commercial blockade imposed by the United States on the island, and the northern country can have access to a drug with excellent results and prospects.

Doctor Elia Neninger, who participated of in the clinical trials of the therapeutic vaccine from the beginning, assured the Russian TV station that the drug has two great advantages: few adverse reactions and a solution to lung cancer, which is a serious health problem in Cuba.

Deputy director of the Molecular Immunology Center Kalet León Monzón said that the patients who have received the vaccine are recovering from advanced tumor cancer and could have the prospect of survival in normal conditions in the very short term, according to Russia Today.

One of the beneficiaries of the vaccine, Miguel Creus, a patient who began to receive Cimavax 15 years ago, when the disease was in stage four and the vaccine was in clinical trials, assures that the drug has prolonged his life with a satisfactory state of health, and that at present he has no traces of tumors or symptoms of the disease.

Despite the effects of the economic blockade of the United States against Cuba, the collaboration between the two institutions continues and Cimavax overcomes the challenges. At present, there are clinical trials that combine this Cuban vaccine with other successful cancer treatments and their effects in high-risk people or patients in the initial stages of the disease are being studied.

According to some studies, lung cancer is the third most frequent cancer in the United States and the deadliest. This Cuban drug could be a promising relief, a good example of the benefits both nations would obtain if they had a normal relationship. (International News Office)

Translated by ESTI

BioCubaFarma broadens collaboration with Belarus

BioCubaFarma broadens collaboration with Belarus
BioCubaFarma deputy director Eulogio Pimentel signs memorandum of understanding to expand cooperation with the Eurasian nation in the biopharmaceutical sector

Author: Internacional news staff | informacion@granmai.cu
june 23, 2022 10:06:01

The Cuban delegation was led by Dr. Eulogio Pimental Vázquez, deputy director of BioCubaFarma.

 

 

 

 

 

 

Photo: BioCubaFarma
Belarussian Minister of Health Dimitri Pinevich received a BioCubaFarma delegation, June 21, visiting the country to discuss efforts to further develop commercial and scientific cooperation in the production of biopreparations and medications, reported Cubaminrex.
Pinevich highlighted the two countries great potential in this field, noting the need to strengthen the current Compensated Exchange Agreement between Cuba and Belarus.
During the Cuban delegation’s stay in the Eurasian nation, deputy director of BioCubaFarma Eulogio Pimentel signed a memorandum of understanding to expand collaboration in the biopharmaceutical sector with the chief executive of the Belarussian BelFarProm holding company.
Cuban scientists also met with pharmaceutical manufacturers to analyze the prospects for bilateral cooperation in the production of medicines and medical devices, and discussed proposals to expand cooperation, including the possible use of Cuban anti-COVID vaccines in Belarus, the Cuban state enterprise group BioCubaFarma reported on social media.

Mexico would be hiring over 500 Cuban doctors.

Mexico president says Cuban doctors, praises Cuban counterpart

 

 

 

 

 

 

ReutersMay 9, 202211:55 AM EDTLast Updated 3 hours ago
Mexico’s President Andres Manuel Lopez Obrador visits Cuba

MEXICO CITY, May 9 (Reuters) – Mexican President Andres Manuel Lopez Obrador on Monday lavished praise on Cuba’s leader, reiterated his wish for the Caribbean island nation to be invited to the Summit of the Americas in June and said Mexico would be hiring over 500 Cuban doctors.

Lopez Obrador, who visited Cuba over the weekend as part of a regional tour of Central America and the Caribbean, said at a regular news conference that he had met with Cuban President Miguel Diaz-Canel, as well as former President Raul Castro.

“They have an incredible president. An honest man, hardworking, human, a really good person,” Lopez Obrador said of Diaz-Canel, the Communist president who took office in 2019.

During the visit the two countries signed an agreement to expand cooperation in public health and another pledging to increase cultural, economic and other ties.

Lopez Obrador has emerged as the most important head of state in Latin America to criticize U.S. policy toward the region and Cuba, which he faults for mass migration, and to call for area integration and greater independence from Washington.

His use of words such as “depraved” to describe U.S. sanctions on Cuba and praise of Cuba’s COVID-19 vaccines have endeared him to the Cuban government

“Except for a couple of short-lived periods in which relations between Cuba and Mexico were tense, during the 63 years since the victory of the Cuban Revolution they have been between good or very good,” William LeoGrande, a professor of government at American University in Washington, said.

“With the advent of AMLO they have become excellent,” he added, referring to Lopez Obrador.

Lopez Obrador again said he wants all countries in the region to receive an invitation to the upcoming U.S.-hosted Summit of the Americas, set to take place in June in Los Angeles. read more

The U.S. government has said Cuba, Nicaragua and Venezuelan President Nicolas Maduro’s administration were unlikely to receive invitations to the summit. read more

Lopez Obrador also announced that Mexico will hire more than 500 Cuban doctors to help make up for a shortage of medical professionals, and that it will purchase COVID-19 vaccines from Cuba.

Cuban doctors were previously hired to work in Mexico earlier in the coronavirus pandemic, sparking criticism from members of Mexico’s opposition. read more

“We are also going to hire doctors from Cuba who are going to come to work in our country. We made this decision because we do not have the doctors we need in the country,” Lopez Obrador said.

The Cuban government did not immediately reply to a Reuters request for comment on Lopez Obrador’s announcement.

The Mexican president announced in April that his country will vaccinate more children against COVID-19, urging global health authorities to deliver the doses it had ordered for the purpose. read more

Mexico will purchase vaccines from Cuba to vaccinate children as young as two years old, he said, adding, “It’s given (Cuba) great results.”

Register now for FREE unlimited access to Reuters.com

Reporting by Ana Isabel Martinez; Writing by Kylie Madry; Editing by Chizu Nomiyama, Anthony Esposito and Bill Berkrot

Our Standards: The Thomson Reuters Trust Principles.